ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/11/20 | 1,080 | 1,083 | 1,036 | 1,042 | -56 | -5.1% | 1,559,500 |
2018/11/19 | 1,028 | 1,123 | 1,028 | 1,098 | +59 | +5.7% | 1,947,200 |
2018/11/16 | 1,081 | 1,091 | 1,036 | 1,039 | -15 | -1.4% | 1,100,100 |
2018/11/15 | 1,026 | 1,077 | 1,023 | 1,054 | +17 | +1.6% | 1,300,500 |
2018/11/14 | 1,047 | 1,073 | 1,019 | 1,037 | -12 | -1.1% | 1,059,700 |
2018/11/13 | 1,003 | 1,058 | 987 | 1,049 | +16 | +1.5% | 1,887,400 |
2018/11/12 | 1,165 | 1,185 | 1,026 | 1,033 | -102 | -9% | 4,769,700 |
2018/11/09 | 1,023 | 1,135 | 1,023 | 1,135 | +150 | +15.2% | 5,425,400 |
2018/11/08 | 1,010 | 1,018 | 978 | 985 | +13 | +1.3% | 1,293,200 |
2018/11/07 | 965 | 997 | 953 | 972 | -7 | -0.7% | 1,546,100 |
2018/11/06 | 958 | 983 | 942 | 979 | +23 | +2.4% | 1,350,000 |
2018/11/05 | 920 | 983 | 918 | 956 | +21 | +2.2% | 1,438,600 |
2018/11/02 | 911 | 954 | 911 | 935 | +58 | +6.6% | 2,400,900 |
2018/11/01 | 862 | 883 | 844 | 877 | ±0 | ±0% | 1,891,400 |
2018/10/31 | 880 | 895 | 857 | 877 | +12 | +1.4% | 1,904,300 |
2018/10/30 | 841 | 878 | 835 | 865 | +23 | +2.7% | 2,443,100 |
2018/10/29 | 873 | 901 | 841 | 842 | -36 | -4.1% | 2,474,300 |
2018/10/26 | 924 | 936 | 844 | 878 | -32 | -3.5% | 4,090,000 |
2018/10/25 | 946 | 949 | 905 | 910 | -77 | -7.8% | 3,542,800 |
2018/10/24 | 1,021 | 1,027 | 978 | 987 | -20 | -2% | 1,771,600 |
2018/10/23 | 1,035 | 1,035 | 998 | 1,007 | -32 | -3.1% | 1,419,000 |
2018/10/22 | 1,010 | 1,044 | 1,005 | 1,039 | +17 | +1.7% | 1,853,200 |
2018/10/19 | 1,054 | 1,062 | 1,021 | 1,022 | -53 | -4.9% | 2,743,100 |
2018/10/18 | 1,110 | 1,120 | 1,071 | 1,075 | -46 | -4.1% | 1,909,900 |
2018/10/17 | 1,142 | 1,159 | 1,112 | 1,121 | -1 | -0.1% | 1,725,900 |
2018/10/16 | 1,115 | 1,136 | 1,096 | 1,122 | +35 | +3.2% | 1,100,300 |
2018/10/15 | 1,125 | 1,132 | 1,085 | 1,087 | -50 | -4.4% | 1,295,700 |
2018/10/12 | 1,099 | 1,145 | 1,090 | 1,137 | +51 | +4.7% | 1,592,400 |
2018/10/11 | 1,032 | 1,108 | 1,030 | 1,086 | -36 | -3.2% | 1,883,700 |
2018/10/10 | 1,123 | 1,136 | 1,092 | 1,122 | +21 | +1.9% | 1,800,700 |
2018/10/09 | 1,169 | 1,173 | 1,092 | 1,101 | -95 | -7.9% | 3,346,200 |
2018/10/05 | 1,212 | 1,237 | 1,184 | 1,196 | -22 | -1.8% | 1,787,200 |
2018/10/04 | 1,253 | 1,268 | 1,210 | 1,218 | -62 | -4.8% | 2,617,300 |
2018/10/03 | 1,309 | 1,320 | 1,278 | 1,280 | -32 | -2.4% | 1,656,900 |
2018/10/02 | 1,325 | 1,332 | 1,286 | 1,312 | +10 | +0.8% | 2,501,400 |
2018/10/01 | 1,360 | 1,368 | 1,284 | 1,302 | -69 | -5% | 3,584,100 |
2018/09/28 | 1,415 | 1,440 | 1,345 | 1,371 | -32 | -2.3% | 4,745,400 |
2018/09/27 | 1,420 | 1,488 | 1,383 | 1,403 | +57 | +4.2% | 10,802,100 |
2018/09/26 | 1,225 | 1,430 | 1,210 | 1,346 | +157 | +13.2% | 15,332,800 |
2018/09/25 | 1,217 | 1,252 | 1,161 | 1,189 | -27 | -2.2% | 6,457,800 |
2018/09/21 | 1,034 | 1,234 | 1,030 | 1,216 | +92 | +8.2% | 22,421,100 |
2018/09/20 | 1,124 | 1,124 | 1,124 | 1,124 | -300 | -21.1% | 169,200 |
2018/09/19 | 1,424 | 1,424 | 1,424 | 1,424 | -400 | -21.9% | 139,500 |
2018/09/18 | 1,802 | 1,855 | 1,775 | 1,824 | +22 | +1.2% | 1,498,000 |
2018/09/14 | 1,779 | 1,810 | 1,748 | 1,802 | +38 | +2.2% | 1,762,400 |
2018/09/13 | 1,673 | 1,774 | 1,672 | 1,764 | +107 | +6.5% | 1,730,000 |
2018/09/12 | 1,704 | 1,740 | 1,650 | 1,657 | -57 | -3.3% | 1,136,000 |
2018/09/11 | 1,688 | 1,722 | 1,657 | 1,714 | +33 | +2% | 1,004,300 |
2018/09/10 | 1,682 | 1,734 | 1,675 | 1,681 | -19 | -1.1% | 756,000 |
2018/09/07 | 1,663 | 1,710 | 1,627 | 1,700 | +7 | +0.4% | 946,200 |
1601~
1650
件表示中 / 5113件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 89,500円 | +20.3% | - | 0.00% | 158.69倍 | 1.18倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 148,200円 | -2.4% | -52.3% | 3.85% | 17.74倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 211,000円 | +4.1% | -3.1% | 2.75% | 18.38倍 | 1.60倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ハートシード | 346,000円 | +174.2% | - | 0.00% | - | 10.38倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
JCRファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム